Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Renforcer les ressources pour les soins de trachéotomie à domicile (BREATHE)

25 septembre 2026 mis à jour par: Karen Sepucha, Massachusetts General Hospital

Renforcer les ressources et l'autonomisation des soignants pour les soins trachologiques à domicile : un essai pragmatique randomisé

The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main questions it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will be randomly assigned to receive Trach Me Home (gold standard discharge program) or Trach Me Home with additional components. Caregiver participants will complete three surveys over the course of 6 months. Researchers will see if caregivers in the Trach Me Home with additional components report lower caregiver burden at 4 weeks post discharge (primary outcome) and fewer hospital readmissions at 6 months than those in Trach Me Home arm.

Aperçu de l'étude

Statut

Inscription sur invitation

Description détaillée

The study is focused on a rare and medically complex population of children with tracheostomies. The study is a Type I hybrid effectiveness-implementation study using a pragmatic randomized trial at six participating sites. The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main question[s] it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will randomly assigned to the Comparator arm (gold standard discharge program) or to the Intervention arm (gold standard program with other components). Caregiver participants will complete three surveys over the course of 6 months. The investigators will test two main hypotheses: the Intervention arm will have (1) significantly lower caregiver burden at 4 weeks post discharge (primary outcome) and (2) significantly lower readmissions or emergency room visits at 6 months post discharge than the Comparator arm.

The investigators will also survey pediatricians of participating patients at 6 months post discharge and examine whether intervention arm pediatricians have higher satisfaction with discharge communication than those in comparator arm.

Type d'étude

Interventionnel

Inscription (Estimé)

480

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • California
      • La Jolla, California, États-Unis, 92093
        • University of San Diego Rady Children's Hospital
    • Maryland
      • Silver Spring, Maryland, États-Unis, 20910
        • Children's National Medical Center, Children's Research Institute
    • Massachusetts
      • Boston, Massachusetts, États-Unis, 02114
        • Massachusetts General Hospital
    • Minnesota
      • Minneapolis, Minnesota, États-Unis, 55404
        • Children's Hospitals and Clinics of Minnesota
    • Ohio
      • Cincinnati, Ohio, États-Unis, 45229
        • Cincinnati Children's Hospital Medical Center
    • Pennsylvania
      • Philadelphia, Pennsylvania, États-Unis, 19146
        • Children's Hospital of Philadelphia

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Lead or primary adult caregiver (18 or older) of infants or children (0-17 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator

Exclusion Criteria:

  • Patients transferred to other hospital or facility (and/or not discharged to home during study period)
  • Primary caregiver unable to read or write in English, Spanish, Mandarin, or Arabic
  • Not residing in the U.S. for at least 12 months after discharge

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Recherche sur les services de santé
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Active Comparator Caregivers

TrachMeHome program delivered in the hospital including education, skills training and case management for caregivers

The Trach Me Home discharge program includes caregiver education, skills training and case management.

Expérimental: Intervention Caregivers

Trach Me Home and Trach Plus with additional education, outpatient care team communication and social support for caregivers.

The Trach Me Home discharge program includes caregiver education, skills training and case management.

The Trach Plus program includes education, social support, and outreach to outpatient care team.

Comparateur actif: Active Comparator Physicians

Primary care physicians' of the enrolled participant's child receiving discharge communication

The Trach Me Home discharge program includes caregiver education, skills training and case management.

Expérimental: Intervention Physicians

Primary care physicians' of the enrolled participant's child receiving outpatient care team communication prior to discharge

The Trach Me Home discharge program includes caregiver education, skills training and case management.

The Trach Plus program includes education, social support, and outreach to outpatient care team.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Caregiver Burden
Délai: 4 weeks post-discharge

Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

4 weeks post-discharge

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Medical Complications Associated with Tracheostomy
Délai: 6 months post-discharge

4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

6 months post-discharge
6-month Readmission Rate
Délai: 6 months post-discharge

Percentage with one or more emergency room visits or hospital readmissions as documented in the electronic health record within 6 months of discharge.

6 months post-discharge
Frequency of pediatrician communication
Délai: 6 months post-discharge

Percentage of pediatrician-specific communication with inpatient team prior to and/or shortly after discharge documented in electronic medical record or by pediatrician report.

6 months post-discharge
Primary care pediatrician satisfaction
Délai: 6 months post-discharge

Clinician reported satisfaction with discharge communication scored from 0-100, higher scores indicate higher satisfaction with discharge communication.

6 months post-discharge
Medical Complications Associated with Tracheostomy
Délai: 4 weeks post-discharge

4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

4 weeks post-discharge
Caregiver Burden
Délai: 6 months post-discharge

Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

6 months post-discharge

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Number of readmissions
Délai: 6 months post discharge

The total number of electronic health record documented emergency room visits and hospital admissions will be collected, with higher numbers being worse (indicating more readmissions).

6 months post discharge

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Karen Sepucha, PhD, Massachusetts General Hospital
  • Chercheur principal: Christopher Hartnick, MD, Massachusetts Eye and Ear Infirmary / Massachusetts General Hospital

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

16 mai 2024

Achèvement primaire (Estimé)

1 décembre 2026

Achèvement de l'étude (Estimé)

1 octobre 2027

Dates d'inscription aux études

Première soumission

21 février 2024

Première soumission répondant aux critères de contrôle qualité

21 février 2024

Première publication (Réel)

28 février 2024

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

30 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

25 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2023P001695
  • IHS-2022C1-26100 (Autre subvention/numéro de financement: Patient Centered Outcomes Research Institute (PCORI))

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

To promote research replicability, transparency and future use of the data, de-identified data sets will be created and will be available, by request, to outside researchers.

The Data Package (comprised of the de-identified Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan, and analytic code from the project) will be deposited in the Patient-Centered Outcomes Research Institute's Data Repository at the ICPSR. Participant information sheets for the study will indicate that de-identified information will be deposited in an open access service to promote use of the data by other researchers. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set. No data will be provided from qualitative transcripts as this may lead to identifying information about participants. However, codes abstracted from qualitative transcripts may be made available.

Délai de partage IPD

After study results have been published, about 1 year after the end of the funded grant period, the study materials and de-identified data will be placed on an open access service such as ICPSR where they will be available indefinitely.

Critères d'accès au partage IPD

Researchers may access the data through the PCORI-designated repository (ICPSR's website) once it is made available.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • SÈVE
  • ANALYTIC_CODE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner